Skip to main content
Top
Published in: Annals of Surgical Oncology 8/2007

01-08-2007 | Thoracic Oncology

Margin and Local Recurrence After Sublobar Resection of Non-Small Cell Lung Cancer

Authors: Amgad El-Sherif, MD, Hiran C. Fernando, MD, Ricardo Santos, MD, Brian Pettiford, MD, James D. Luketich, MD, John M. Close, MA, Rodney J. Landreneau, MD

Published in: Annals of Surgical Oncology | Issue 8/2007

Login to get access

Abstract

Background

Local recurrence is a major concern after sublobar resection (SR) of non-small cell lung cancer (NSCLC). We postulate that a large proportion of local recurrence is related to inadequate resection margins. This report analyzes local recurrence after SR of stage I NSCLC. Stratification based on distance of the tumor (<1 cm vs ≥1 cm) to the staple line was performed.

Methods

We reviewed 81 NSCLC patients (44 female) who underwent operation over an 89-month period (January 1997 to June 2004). Mean forced expiratory volume in one second percentiles (FEV1) was 57%. Mean age was 70 (46–86) years. There were 55 wedge and 26 segmental resections. There were 41 tumors with a margin <1 cm and 40 with a margin ≥1 cm. Local recurrence was defined as recurrence within the ipsilateral lung or pulmonary hilum.

Results

There were no perioperative deaths. Mean follow-up was 20 months. Margin distance significantly impacted local recurrence; 6 of 41 patients (14.6%) developed local recurrence in the group with margin less than 1 cm versus 3 of 40 patients (7.5%) in the group with margin equal to or more than 1 cm (P = .04). Of the 41 patients with margins <1 cm, segmentectomy was used in 7 (17%), whereas in the 40 patients with the ≥1 cm margins, segmentectomy was used in 19 (47.5%).

Conclusions

Margin is an important consideration after SR of NSCLC. Wedge resection is frequently associated with margins less than 1 cm and a high risk for locoregional recurrence. Segmentectomy appears to be a better choice of SR when this is chosen as therapy.
Literature
1.
go back to reference Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Ann Thorac Surg 1995; 60: 615–623PubMedCrossRef Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Ann Thorac Surg 1995; 60: 615–623PubMedCrossRef
2.
go back to reference Landreneau RJ, Sugarbaker DJ, Mack MJ, et al. Wedge resection versus lobectomy for stage I (T1 N0 M0) Non-small cell lung cancer. J Thorac Cardiovasc Surg 1997; 113:691–700PubMedCrossRef Landreneau RJ, Sugarbaker DJ, Mack MJ, et al. Wedge resection versus lobectomy for stage I (T1 N0 M0) Non-small cell lung cancer. J Thorac Cardiovasc Surg 1997; 113:691–700PubMedCrossRef
3.
go back to reference Mountain CF. Revisions in the International System for staging lung cancer. Chest 1997; 111:1710–7PubMed Mountain CF. Revisions in the International System for staging lung cancer. Chest 1997; 111:1710–7PubMed
4.
5.
go back to reference Keenan RJ, Landreneau RJ, Maley RH Jr. Singh D, Macherey R, Bartley S, Santucci T. Segmental resection spares pulmonary function in patients with stage I lung cancer. Ann Thorac Surg 2004; 78(1):228–233CrossRef Keenan RJ, Landreneau RJ, Maley RH Jr. Singh D, Macherey R, Bartley S, Santucci T. Segmental resection spares pulmonary function in patients with stage I lung cancer. Ann Thorac Surg 2004; 78(1):228–233CrossRef
6.
go back to reference Higashiyama M, Kodama K, Takami K, Higaki N, Nakayama T, Yokouchi H. Intraoperative lavage cytologic analysis of surgical margins in patients undergoing limited surgery for lung cancer. J Thorac Cardiovasc Surg 2003; 125:101–7PubMedCrossRef Higashiyama M, Kodama K, Takami K, Higaki N, Nakayama T, Yokouchi H. Intraoperative lavage cytologic analysis of surgical margins in patients undergoing limited surgery for lung cancer. J Thorac Cardiovasc Surg 2003; 125:101–7PubMedCrossRef
7.
go back to reference Sawabata N, Matsumura A, Ohota M, Maeda H, Hirano H, Nakagawa K, Matsuda H. Cytologically malignant margins of wedge resected stage I Non-small cell lung cancer. Ann Thorac Surg 2002; 74:1953–7PubMedCrossRef Sawabata N, Matsumura A, Ohota M, Maeda H, Hirano H, Nakagawa K, Matsuda H. Cytologically malignant margins of wedge resected stage I Non-small cell lung cancer. Ann Thorac Surg 2002; 74:1953–7PubMedCrossRef
8.
go back to reference Sawabata N, Ohta M, Matsumura A, Nakagawa K, Hirano H, Maeda H, Matsuda H. Optimal distance of malignant negative margin excision of non-small cell lung cancer: a multicenter prospective study. Ann Thorac Surg 2004; 77(2):415–20CrossRef Sawabata N, Ohta M, Matsumura A, Nakagawa K, Hirano H, Maeda H, Matsuda H. Optimal distance of malignant negative margin excision of non-small cell lung cancer: a multicenter prospective study. Ann Thorac Surg 2004; 77(2):415–20CrossRef
9.
go back to reference Fell SC, Kirby TJ. Limited pulmonary resection. Thoracic Surgery, 2nd ed. New York: Churchill Livingstone. 2002; 36:1002–4 Fell SC, Kirby TJ. Limited pulmonary resection. Thoracic Surgery, 2nd ed. New York: Churchill Livingstone. 2002; 36:1002–4
10.
go back to reference Lewis RJ. The role of video assisted thoracic surgery for carcinoma of the lung: wedge resection to lobectomy by simultaneous individual stapling. Ann Thorac Surg 1993; 56:762–8PubMedCrossRef Lewis RJ. The role of video assisted thoracic surgery for carcinoma of the lung: wedge resection to lobectomy by simultaneous individual stapling. Ann Thorac Surg 1993; 56:762–8PubMedCrossRef
11.
go back to reference Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, Tsubota N. Effect of tumor size on prognosis in patients with non-small cell lung cancer: The role of segmentectomy as a type of lesser resection. J Thorac Cardiovasc Surg 2005; 129(1):87–93PubMedCrossRef Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, Tsubota N. Effect of tumor size on prognosis in patients with non-small cell lung cancer: The role of segmentectomy as a type of lesser resection. J Thorac Cardiovasc Surg 2005; 129(1):87–93PubMedCrossRef
12.
go back to reference Miller JI, Hatcher CR. Limited resection of bronchogenic carcinoma in the patient with marked impairment of pulmonary function. Ann Thorac Surg 1987; 44:340–3PubMedCrossRef Miller JI, Hatcher CR. Limited resection of bronchogenic carcinoma in the patient with marked impairment of pulmonary function. Ann Thorac Surg 1987; 44:340–3PubMedCrossRef
13.
go back to reference Shennib H, Bogart JA, Herndon J, et al. Thoracoscopic wedge resection and radiotherapy for T1N0 non-small cell lung cancer (NSCLC) in high risk patients: preliminary analysis of a Cancer and Leukemia Group B and Eastern Cooperative Oncology Group phase II trial (abstract 240). Int J Radiat Oncol Bio Phys 2000; 48(suppl):232CrossRef Shennib H, Bogart JA, Herndon J, et al. Thoracoscopic wedge resection and radiotherapy for T1N0 non-small cell lung cancer (NSCLC) in high risk patients: preliminary analysis of a Cancer and Leukemia Group B and Eastern Cooperative Oncology Group phase II trial (abstract 240). Int J Radiat Oncol Bio Phys 2000; 48(suppl):232CrossRef
14.
go back to reference D'Amato TA , Galloway M, Szydlowski G, Chen A, Landreneau RJ. Intraoperative brachytherapy following thoracoscopic wedge resection of stage I lung cancer. Chest 1998; 114:1112–5PubMed D'Amato TA , Galloway M, Szydlowski G, Chen A, Landreneau RJ. Intraoperative brachytherapy following thoracoscopic wedge resection of stage I lung cancer. Chest 1998; 114:1112–5PubMed
15.
go back to reference Santos R, Colonias A, Parda D, et al. Comparison between sublobar resection and I125 brachytherapy following sublobar resection in high-risk patients with stage I non-small cell cancer. Surgery 2003; 134:691–7PubMedCrossRef Santos R, Colonias A, Parda D, et al. Comparison between sublobar resection and I125 brachytherapy following sublobar resection in high-risk patients with stage I non-small cell cancer. Surgery 2003; 134:691–7PubMedCrossRef
16.
go back to reference Fernando HC, Santos RS, Benfield JR, et al. Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg 2005; 129:261–7PubMedCrossRef Fernando HC, Santos RS, Benfield JR, et al. Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg 2005; 129:261–7PubMedCrossRef
17.
go back to reference Lee W, Daly BD, DiPetrillo TA, Morelli DA, Neuschatz AC, Morr J, Rivard MJ. Limited resection for non-small cell lung cancer: observed local control with implantation of I125 brachytherapy seeds. Ann Thorac Surg 2003; 75:237–42PubMedCrossRef Lee W, Daly BD, DiPetrillo TA, Morelli DA, Neuschatz AC, Morr J, Rivard MJ. Limited resection for non-small cell lung cancer: observed local control with implantation of I125 brachytherapy seeds. Ann Thorac Surg 2003; 75:237–42PubMedCrossRef
18.
go back to reference Birdas TJ, Koehler RPM, Colonias A, Trombetta Jr. M, Maley RH, Landreneau RJ, Keenan RJ. Sublobar resection with brachytherapy versus lobectomy in stage IB nonsmall cell lung cancer. Ann Thorac Surg 2006; 81:434–8PubMedCrossRef Birdas TJ, Koehler RPM, Colonias A, Trombetta Jr. M, Maley RH, Landreneau RJ, Keenan RJ. Sublobar resection with brachytherapy versus lobectomy in stage IB nonsmall cell lung cancer. Ann Thorac Surg 2006; 81:434–8PubMedCrossRef
Metadata
Title
Margin and Local Recurrence After Sublobar Resection of Non-Small Cell Lung Cancer
Authors
Amgad El-Sherif, MD
Hiran C. Fernando, MD
Ricardo Santos, MD
Brian Pettiford, MD
James D. Luketich, MD
John M. Close, MA
Rodney J. Landreneau, MD
Publication date
01-08-2007
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 8/2007
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-007-9421-9

Other articles of this Issue 8/2007

Annals of Surgical Oncology 8/2007 Go to the issue